NAMS
NewAmsterdam Pharma Company NV
3월 13일 4:00 PM ET (한국 3/14 05:00)
$28.62
-1.20 ▼ -4.02%
🌙 3월 13일 7:33 PM ET (한국 3/14 08:33)
$29.17
+0.55 ▲ +1.92%
| Index | - | P/E | - | EPS (ttm) | -1.75 | Insider Own | 37.34% | Shs Outstand | 0.11B | Perf Week | -4.15% |
| Market Cap | 3.29B | Forward P/E | - | EPS next Y | 29.36% | Insider Trans | -3.53% | Shs Float | 0.07B | Perf Month | -16.41% |
| Enterprise Value | 2.65B | PEG | - | EPS next Q | -0.49 | Inst Own | 67.92% | Short Float | 10.63% | Perf Quarter | -19.63% |
| Income | -0.20B | P/S | 146.25 | EPS this Y | -12.18% | Inst Trans | 1.57% | Short Ratio | 9.85 | Perf Half Y | 7.59% |
| Sales | 0.02B | P/B | 4.79 | EPS next 5Y | 60.99% | ROA | -24.95% | Short Interest | 7.66M | Perf YTD | -18.42% |
| Book/sh | 5.97 | P/C | 5.16 | EPS past 3/5Y | -12.98% - | ROE | -28.29% | 52W High | -31.86% ($42.00) | Perf Year | 21.37% |
| Cash/sh | 5.55 | P/FCF | - | Sales past 3/5Y | -39.71% - | ROIC | -29.82% | 52W Low | 103.56% ($14.06) | Perf 3Y | 119.65% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 32.78% | Gross Margin | 99.02% | Volatility(W/M) | 6.21% 5.73% | Perf 5Y | 183.09% |
| Dividend TTM | - | EV/Sales | 117.92 | Sales Y/Y TTM | -50.61% | Oper. Margin | -1002.9% | ATR (14) | 1.83 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.88 | EPS Q/Q | 31.06% | Profit Margin | -905.74% | RSI (14) | 34.08 | Recom | 1.13 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.88 | Sales Q/Q | -99.75% | SMA20 | -13.14% ($32.95) | Beta | 0.13 | Target Price | $49.77 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | -13.75% ($33.18) | Rel Volume | 1.24 | Prev Close | $29.82 |
| Employees | 100 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -11.64% -98.02% | SMA200 | -3.4% ($29.63) | Avg Volume(3M) | 0.78M | Price | $28.62 |
| IPO | 2021/2/8 | Option/Short | Yes/Yes | Trades | 7007 | Volume | 965,085 | Change | -4.02% |
뉴스 로딩 중...